MED and FAS against Vekselberg's monopoly on catheter market
Stentex offered to oblige all Russian hospitals to buy equipment of only its production.
The Ministry of Economic Development (MED) and the Federal Antimonopoly Service (FAS) opposed the idea to oblige hospitals to buy Russian coronary stents and catheters only in Stentex company - a joint project of billionaire Viktor Vekselberg and international manufacturer of medical equipment Medtronic.
Earlier it was reported that in May 2015 Stentex became, according to the order of the Government, the sole supplier of stents (devices-implants for the dilatation of narrowed vessels - Ed.). And catheters, which are used for heart disease. Thus, according to the current legislation, allows hospitals to conclude contracts on the purchase of equipment without competition. However, Stentex found it insufficient and proposed to oblige hospitals to carry out the purchase without competition only directly from the company.
At the Ministry of Economic Development's letter, as RBC writes, signed by Deputy Minister Evgeny Yelin, stated that Stentex, according to the agency, signed contracts with only nine out of 200 hospitals, procuring stents and catheters. "A large part of health care institutions refuse to conclude contracts directly with a single supplier, announcing bids for the purchase of catheters and stents," the document says.
In addition, the Vekselberg's company manufactures equipment in insufficient for the Russian market quantity, Stentex product prices are by an average of 22.2 -28 thousand rubles higher than of its nearest competitor, the manufacturer of the Novosibirsk Angioline. As a result, the Ministry of Economic Development considered inexpedient to grant the request of the Vekselberg’s company.
According to the investigation, having taken a five-billion loan ($88.7m) from Sberbank in 2008, the owner of Pavlovskgranit deliberately split up the assets of the company so that creditors could not bring a charge against him to court.